Stelac Advisory Services LLC Bristol Myers Squibb CO Transaction History

Stelac Advisory Services LLC

$239 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $26,057 - $28,932	-409 Reduced 5.87%	6,559 $419,000
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $394 - $447	6 Added 0.09%	6,968 $482,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $48,209 - $57,087	-704 Reduced 9.18%	6,962 $500,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $356,854 - $393,021	4,914 Added 178.56%	7,666 $590,000
Q1 2022 Jun 28, 2022	SELL	$61.48 - $73.72 $106,852 - $128,125	-1,738 Reduced 38.71%	2,752 $201,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $210,569 - $252,491	-3,425 Reduced 43.27%	4,490 $328,000
Q4 2021 Jun 28, 2022	BUY	$53.63 - $62.52 $37,916 - $44,201	707 Added 9.81%	7,915 $494,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $60,172 - $70,147	-1,122 Reduced 13.47%	7,208 $449,000
Q3 2021 Jun 28, 2022	SELL	$59.17 - $69.31 $102,837 - $120,460	-1,738 Reduced 17.26%	8,330 $493,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $83,548 - $97,865	1,412 Added 16.31%	10,068 $596,000
Q2 2021 Jun 28, 2022	SELL	$61.91 - $67.42 $154,279 - $168,010	-2,492 Reduced 22.35%	8,656 $578,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $467,420 - $509,021	7,550 Added 209.84%	11,148 $745,000
Q1 2021 Jun 28, 2022	SELL	$59.34 - $66.74 $147,875 - $166,316	-2,492 Reduced 40.92%	3,598 $227,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $9,850 - $11,078	166 Added 2.8%	6,090 $384,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $156,071 - $176,857	2,703 Added 83.92%	5,924 $367,000
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $4,824 - $5,345	84 Added 2.68%	3,221 $194,000
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $171,970 - $201,050	3,137 New	3,137 $184,000
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $106,633 - $116,257	-1,779 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $98,254 - $113,393	1,779	1,779 $113,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stelac Advisory Services LLC with notifications on news.

Account